Global Trust Asset Management LLC Acquires 57 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Global Trust Asset Management LLC raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 3.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,674 shares of the healthcare conglomerate’s stock after acquiring an additional 57 shares during the quarter. Global Trust Asset Management LLC’s holdings in UnitedHealth Group were worth $847,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. BlackBarn Capital Partners LP boosted its holdings in shares of UnitedHealth Group by 6.7% in the second quarter. BlackBarn Capital Partners LP now owns 32,000 shares of the healthcare conglomerate’s stock valued at $16,296,000 after buying an additional 2,000 shares during the period. Insigneo Advisory Services LLC raised its position in UnitedHealth Group by 9.0% in the 2nd quarter. Insigneo Advisory Services LLC now owns 10,890 shares of the healthcare conglomerate’s stock valued at $5,546,000 after buying an additional 897 shares during the last quarter. Lone Pine Capital LLC acquired a new position in UnitedHealth Group during the 2nd quarter worth approximately $480,903,000. Fred Alger Management LLC raised its holdings in shares of UnitedHealth Group by 16.7% in the second quarter. Fred Alger Management LLC now owns 103,957 shares of the healthcare conglomerate’s stock valued at $52,941,000 after purchasing an additional 14,880 shares during the last quarter. Finally, Point72 Hong Kong Ltd grew its position in UnitedHealth Group by 11.2% in the second quarter. Point72 Hong Kong Ltd now owns 22,069 shares of the healthcare conglomerate’s stock valued at $11,239,000 after purchasing an additional 2,221 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $519.08 on Thursday. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The firm has a market capitalization of $477.70 billion, a P/E ratio of 33.49, a P/E/G ratio of 1.42 and a beta of 0.62. The stock’s 50-day simple moving average is $545.26 and its two-hundred day simple moving average is $564.10.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same period in the previous year, the business earned $5.83 earnings per share. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.75 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.62%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.19%.

Wall Street Analysts Forecast Growth

UNH has been the topic of several analyst reports. UBS Group dropped their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. KeyCorp reissued an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Truist Financial decreased their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. TD Cowen raised their target price on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research note on Friday, October 18th. Finally, StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday. One analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Buy” and an average target price of $627.74.

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.